Brief: Fulcrum Therapeutics Q1 Basic EPS USD -0.28
01/05/2025 12:00
May 01 (Reuters) - Fulcrum Therapeutics Q1 operating expenses USD 20.403 million. Q1 operating income USD -20.403 million Q1 net income USD -17.655 million
Recent news on Fulcrum Therapeutics
See all newsFulcrum down after announcing restructuring, plans to cut 85% jobs
Brief: Fulcrum Therapeutics Approves Restructuring Plan After Discontinuing Pociredir For Sickle Cell Disease
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Fulcrum
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Philip Morris
Fulcrum falls after discontinuing sickle cell drug program